Publicacións (23) Publicacións de Francisco José Maceiras Pan

2024

  1. Real-world apremilast use in biologic-naïve psoriatic arthritis patients. Data from Spanish clinical practice

    Reumatologia Clinica, Vol. 20, Núm. 1, pp. 24-31

  2. Semaphorin3B promotes an anti-inflammatory and pro-resolving phenotype in macrophages from rheumatoid arthritis patients in a MerTK-dependent manner

    Frontiers in Immunology, Vol. 14

2023

  1. The activity of psoriatic arthritis with axial involvement correlates with the PsAID12

    Reumatologia Clinica

2022

  1. Analysis of the implementation of an innovative IT solution to improve waiting times, communication with primary care and efficiency in Rheumatology

    BMC Health Services Research, Vol. 22, Núm. 1

2021

  1. Direct costs in patients with chronic inflammatory arthropathies on biological therapy: A real-world data study

    Clinical and Experimental Rheumatology, Vol. 39, Núm. 4, pp. 736-745

  2. Epidemiological Characteristics and Adverse Events of Patients with Psoriatic Arthritis Undergoing Treatment with Biological Therapies in Galicia

    Reumatologia Clinica, Vol. 17, Núm. 3, pp. 150-154

  3. Medication persistence on biological therapies prescribed for the treatment of chronic inflammatory arthropathies: a real-world data study

    European Journal of Hospital Pharmacy, Vol. 28, Núm. e1, pp. E47-E50

  4. Secukinumab as Biological Treatment for Psoriatic Arthritis in Real Clinical Practice

    Reumatologia Clinica, Vol. 17, Núm. 4, pp. 203-206

2020

  1. Current status of multidisciplinary care in psoriatic arthritis in Spain: NEXUS 2.0 project

    Reumatologia Clinica, Vol. 16, Núm. 1, pp. 24-31

  2. Efficacy and Safety of Combined Therapy With Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Systematic Literature Review

    Reumatologia Clinica, Vol. 16, Núm. 5P1, pp. 324-332

  3. Satisfaction, fulfillment of expectations and adherence to subcutaneous biological drugs in patients with rheumatoid arthritis: ARCO study

    Reumatologia Clinica, Vol. 16, Núm. 2P1, pp. 116-119

2019

  1. Adherence to biological therapies in patients with chronic inflammatory arthropathies

    Farmacia Hospitalaria, Vol. 43, Núm. 4, pp. 134-139

  2. Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology

    Reumatologia Clinica, Vol. 15, Núm. 5, pp. 252-257

2017

  1. Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: A multicentre, non-interventional study

    Clinical and Experimental Rheumatology, Vol. 35, Núm. 3, pp. 423-430

2006

  1. Desarrollo y validación de un cuestionario de satisfacción con el tratamiento en pacientes con artritis reumatoide

    Reumatologia Clinica, Vol. 2, Núm. 3, pp. 137-145

  2. Piomiositis: Presentación de 17 casos en niños y adultos

    Revista Medica de Chile, Vol. 134, Núm. 1, pp. 31-38

2004

  1. Effect of the first infliximab infusion on sleep and alertness in patients with active rheumatoid arthritis

    Annals of the Rheumatic Diseases, Vol. 63, Núm. 1, pp. 88-90

  2. Worsening of obstructive sleep apnoeas in a patient with rheumatoid arthritis treated with anti-tumor necrosis factor

    Respiratory Medicine, Vol. 98, Núm. 2, pp. 123-125

2003

  1. Erratum: Fatal Kikuchi-Fujimoto disease: The lupus connection (Annals of Hematology (2003) vol. 82 (186-188))

    Annals of Hematology

  2. Fatal Kikuchi-Fujimoto disease: The lupus connection

    Annals of Hematology, Vol. 82, Núm. 3, pp. 186-188